{"transactions":[{"id":982517,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-03T16:19:16.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":16401,"price":2.9002,"value":47566.1802,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":358686,"source":{"system":"sec-edgar","filing":"0001945797-25-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000194579725000002/primarydocument.xml","form_type":"4"}},{"id":1048643,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T18:34:13.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4578,"price":3.3627,"value":15394.4406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":375087,"source":{"system":"sec-edgar","filing":"0001562180-25-006104","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218025006104/primarydocument.xml","form_type":"4"}},{"id":1126213,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T21:05:55.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4747,"price":3.6348,"value":17254.3956,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":379665,"source":{"system":"sec-edgar","filing":"0001562180-25-004392","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218025004392/primarydocument.xml","form_type":"4"}},{"id":1231809,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T17:21:15.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":10800,"price":4.5771,"value":49432.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":384412,"source":{"system":"sec-edgar","filing":"0001562180-25-002006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218025002006/primarydocument.xml","form_type":"4"}},{"id":1250733,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-24T20:49:59.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":18262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of 18,262 performance-based restricted units (\"PRSUs\") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":395212,"source":{"system":"sec-edgar","filing":"0001562180-25-001551","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218025001551/primarydocument.xml","form_type":"4"}},{"id":1250732,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-24T20:49:59.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments."}],"balance_after":376950,"source":{"system":"sec-edgar","filing":"0001562180-25-001551","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218025001551/primarydocument.xml","form_type":"4"}},{"id":1345931,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T16:05:52.000Z","date":"2024-12-02","kind":"sale","planned":false,"acquired":false,"shares":7500,"price":8.9431,"value":67073.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1."}],"balance_after":236950,"source":{"system":"sec-edgar","filing":"0001562180-24-008097","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024008097/primarydocument.xml","form_type":"4"}},{"id":1345930,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T16:05:52.000Z","date":"2024-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":11431,"price":8.9732,"value":102572.6492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":244450,"source":{"system":"sec-edgar","filing":"0001562180-24-008097","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024008097/primarydocument.xml","form_type":"4"}},{"id":1414554,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:42:11.000Z","date":"2024-09-03","kind":"sale","planned":false,"acquired":false,"shares":7500,"price":7.2232,"value":54174.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1."}],"balance_after":255881,"source":{"system":"sec-edgar","filing":"0001562180-24-006686","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024006686/primarydocument.xml","form_type":"4"}},{"id":1414553,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-05T16:42:11.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2772,"price":7.2691,"value":20149.9452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":263381,"source":{"system":"sec-edgar","filing":"0001562180-24-006686","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024006686/primarydocument.xml","form_type":"4"}},{"id":1482551,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-12T16:25:49.000Z","date":"2024-06-11","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":6.5344,"value":49008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 11th, 2024 in accordance with Rule 10b5-1."}],"balance_after":266153,"source":{"system":"sec-edgar","filing":"0001562180-24-004989","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024004989/primarydocument.xml","form_type":"4"}},{"id":1493546,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-04T16:13:56.000Z","date":"2024-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2951,"price":6.5333,"value":19279.7683,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":273653,"source":{"system":"sec-edgar","filing":"0001562180-24-004628","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024004628/primarydocument.xml","form_type":"4"}},{"id":1599200,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-05T16:14:34.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4540,"price":8.0512,"value":36552.448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":276604,"source":{"system":"sec-edgar","filing":"0001562180-24-002254","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024002254/primarydocument.xml","form_type":"4"}},{"id":1626337,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T19:34:17.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of 3,334 performance-based restricted units (\"PRSUs\") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Each PRSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":281144,"source":{"system":"sec-edgar","filing":"0001562180-24-001656","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024001656/primarydocument.xml","form_type":"4"}},{"id":1626336,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T19:34:17.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments."}],"balance_after":277810,"source":{"system":"sec-edgar","filing":"0001562180-24-001656","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218024001656/primarydocument.xml","form_type":"4"}},{"id":1722657,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-12-05T17:38:41.000Z","date":"2023-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2921,"price":7.4503,"value":21762.3263,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":167810,"source":{"system":"sec-edgar","filing":"0001562180-23-008132","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218023008132/primarydocument.xml","form_type":"4"}},{"id":1787938,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T20:46:58.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8460,"price":11.7765,"value":99629.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":170731,"source":{"system":"sec-edgar","filing":"0001562180-23-006762","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218023006762/primarydocument.xml","form_type":"4"}},{"id":1868102,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-06-05T19:32:05.000Z","date":"2023-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1038,"price":11.239,"value":11666.082,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 700 shares that were previously reported as held by the Reporting Person due to an inadvertent administrative error."}],"balance_after":179191,"source":{"system":"sec-edgar","filing":"0001562180-23-004860","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218023004860/primarydocument.xml","form_type":"4"}},{"id":1975955,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T17:09:12.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":1264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an award of 1,264 PRSUs pursuant to the 2019 Plan. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2022, 25% of the PRSUs noted above vested on March 1, 2023 and, thereafter, the remaining 75% of the PRSUs will vest in 12 equal quarterly installments."}],"balance_after":180929,"source":{"system":"sec-edgar","filing":"0001562180-23-002427","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218023002427/primarydocument.xml","form_type":"4"}},{"id":1975954,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T17:09:12.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":1819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of 1,819 performance-based restricted units (\"PRSUs\") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2022, the PRSUs noted above vested on March 1, 2023."}],"balance_after":179665,"source":{"system":"sec-edgar","filing":"0001562180-23-002427","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218023002427/primarydocument.xml","form_type":"4"}},{"id":1975953,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T17:09:12.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":1569,"price":14.2886,"value":22418.8134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":177846,"source":{"system":"sec-edgar","filing":"0001562180-23-002427","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218023002427/primarydocument.xml","form_type":"4"}},{"id":2096996,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Common Stock","published_at":"2022-12-05T16:38:53.000Z","date":"2022-12-01","kind":"tax_withholding","acquired":false,"shares":2446,"price":10.6497,"value":26049.1662,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":179415,"source":{"system":"sec-edgar","filing":"0001562180-22-008055","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218022008055/primarydocument.xml","form_type":"4"}},{"id":2161621,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":72318,"kind":"person","name":"Freeman Kevin Lee","position":1,"cik":"0001945797","reported_name":"Freeman Kevin Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Common Stock","published_at":"2022-09-12T18:13:21.000Z","date":"2022-09-08","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on September 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments."}],"balance_after":181861,"source":{"system":"sec-edgar","filing":"0001562180-22-006615","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945797/000156218022006615/primarydocument.xml","form_type":"4"}}]}